FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 171 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 12.90 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,000 | – | 185 | +640.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 25 | -43.2% | 0.00% | – |
| Q3 2018 | $1,000 | – | 44 | +633.3% | 0.00% | – |
| Q4 2017 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 6 | -95.7% | 0.00% | – |
| Q2 2016 | $6,000 | +50.0% | 141 | +29.4% | 0.00% | – |
| Q1 2016 | $4,000 | -99.5% | 109 | -99.4% | 0.00% | -100.0% |
| Q4 2015 | $776,000 | +171.3% | 18,705 | +0.6% | 0.00% | – |
| Q3 2015 | $286,000 | +4.4% | 18,600 | +69.1% | 0.00% | – |
| Q2 2015 | $274,000 | +8.7% | 11,000 | 0.0% | 0.00% | – |
| Q1 2015 | $252,000 | -15.4% | 11,000 | 0.0% | 0.00% | – |
| Q4 2014 | $298,000 | +127.5% | 11,000 | -1.1% | 0.00% | – |
| Q3 2014 | $131,000 | -24.7% | 11,120 | 0.0% | 0.00% | – |
| Q2 2014 | $174,000 | – | 11,120 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eventide Asset Management | 1,085,200 | $44,873,000 | 2.75% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 328,329 | $13,576,000 | 0.94% |
| HAYS ADVISORY LLC | 135,722 | $5,612,000 | 0.87% |
| AWM Investment Company, Inc. | 90,000 | $3,721,000 | 0.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 448,000 | $18,525,000 | 0.73% |
| SPHERA FUNDS MANAGEMENT LTD. | 60,000 | $2,481,000 | 0.64% |
| RTW INVESTMENTS, LP | 44,701 | $1,848,000 | 0.63% |
| Telemetry Investments, L.L.C. | 26,000 | $1,075,000 | 0.58% |
| Spark Investment Management LLC | 148,100 | $6,123,000 | 0.57% |
| Perceptive Advisors | 169,439 | $7,006,000 | 0.49% |